These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16377145)

  • 41. Is it ethical to use placebos in osteoporosis trials?
    Ragi-Eis S; Zerbini CA; Provenza JR; Griz LH; de Gregório LH; Russo LA; Silva NA; Borges JL; de Souza AC; Castro ML; Lewiecki EM
    J Clin Densitom; 2006; 9(3):274-80. PubMed ID: 16931344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monotherapy in adults and elderly persons.
    Faught E
    Neurology; 2007 Dec; 69(24 Suppl 3):S3-9. PubMed ID: 18071156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interpreting regulatory trials in epilepsy.
    Marson AG; Williamson PR
    Curr Opin Neurol; 2009 Apr; 22(2):167-73. PubMed ID: 19532041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
    Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
    J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric trials: practical issues. Special populations and trial design.
    Pellock JM
    Adv Neurol; 1998; 76():167-71. PubMed ID: 9408474
    [No Abstract]   [Full Text] [Related]  

  • 46. Alternatives for discounting in the analysis of noninferiority trials.
    Snapinn SM
    J Biopharm Stat; 2004 May; 14(2):263-73. PubMed ID: 15206525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a place for placebo controlled trials of antiepileptic drugs?
    Shorvon SD; Espir ML; Steiner TJ; Dellaportas CI; Rose FC
    Br Med J (Clin Res Ed); 1985 Nov; 291(6505):1328-9. PubMed ID: 3933653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Avoiding ambiguity with the Type I error rate in noninferiority trials.
    Kang SH
    J Biopharm Stat; 2016; 26(3):452-65. PubMed ID: 26252624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monotherapy comparative trials: placebos and suboptimal comparators.
    Schwabe S
    Epilepsy Res; 2001 May; 45(1-3):93-6; discussion 97-9. PubMed ID: 11461805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patients' willingness to participate in placebo-controlled trials of antihypertensive therapy.
    Al-Khatib SM; Biswas MS
    Am Heart J; 2003 Dec; 146(6):944-5. PubMed ID: 14660983
    [No Abstract]   [Full Text] [Related]  

  • 51. The pros and cons of noninferiority trials.
    Pocock SJ
    Fundam Clin Pharmacol; 2003 Aug; 17(4):483-90. PubMed ID: 12914552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical trials for prevention of epileptogenesis.
    Herman ST
    Epilepsy Res; 2006 Jan; 68(1):35-8. PubMed ID: 16377141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Which should be the first-line drug for newly diagnosed epilepsy? Commentary on the SANAD study.
    Neligan A; Shorvon SD
    Pol Arch Med Wewn; 2008; 118(1-2):11-3. PubMed ID: 18405167
    [No Abstract]   [Full Text] [Related]  

  • 54. Monotherapy comparative trials: equivalence and differences in clinical trials.
    Chadwick D
    Epilepsy Res; 2001 May; 45(1-3):101-3; discussion 105-7. PubMed ID: 11461807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The virtual patient -- addressing the placebo challenge.
    Higgins A
    Vet J; 2001 Jul; 162(1):1-2. PubMed ID: 11409921
    [No Abstract]   [Full Text] [Related]  

  • 56. Creation and implementation of a historical controls database from randomized clinical trials.
    Desai JR; Bowen EA; Danielson MM; Allam RR; Cantor MN
    J Am Med Inform Assoc; 2013 Jun; 20(e1):e162-8. PubMed ID: 23449762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecule of the month. Lacosamide.
    Drug News Perspect; 2004 Dec; 17(10):689. PubMed ID: 15696232
    [No Abstract]   [Full Text] [Related]  

  • 58. Should we reconsider the routine use of placebo controls in clinical research?
    Avins AL; Cherkin DC; Sherman KJ; Goldberg H; Pressman A
    Trials; 2012 Apr; 13():44. PubMed ID: 22540350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Type I error probabilities based on design-stage strategies with applications to noninferiority trials.
    Rothmann M
    J Biopharm Stat; 2005; 15(1):109-27. PubMed ID: 15702608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Do anticonvulsants alter the natural course of epilepsy? Treatment should be started as early as possible.
    Reynolds EH
    BMJ; 1995 Jan; 310(6973):176-7. PubMed ID: 7833760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.